+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Immunohematology Market by Product Type (Analyzers & Systems, Reagents & Kits), Application (Antibody Screening, Blood Transfusion, Disease Diagnosis), End-User - Global Forecast 2025-2030- Product Image
Immunohematology Market by Product Type (Analyzers & Systems, Reagents & Kits), Application (Antibody Screening, Blood Transfusion, Disease Diagnosis), End-User - Global Forecast 2025-2030- Product Image
Sale

Immunohematology Market by Product Type (Analyzers & Systems, Reagents & Kits), Application (Antibody Screening, Blood Transfusion, Disease Diagnosis), End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5454916
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Immunohematology is evolving rapidly, offering critical advancements in blood safety diagnostics and patient care pathways. Senior decision-makers in healthcare, diagnostics, and laboratory operations must keep pace with innovations reshaping transfusion medicine, operational models, and global regulatory frameworks. This report delivers strategic insights for leveraging the immunohematology market’s most impactful trends.

Market Snapshot: Immunohematology Market Value and Growth

The Immunohematology Market grew from USD 2.22 billion in 2024 to USD 2.40 billion in 2025. It is expected to continue growing at a CAGR of 8.27%, reaching USD 3.59 billion by 2030. This sustained expansion reflects the sector’s strong response to rising demand for precision diagnostics, regulatory compliance, and operational efficiency worldwide.

Scope & Segmentation

This report provides an in-depth analysis of the immunohematology market, focusing on major product types, applications, end users, and geographic regions. Leaders can assess opportunities and challenges through the following segmented lenses:

  • Product Types: Analyzers & Systems (covering both fully-automated platforms for high-volume laboratories and semi-automated options for mid-sized facilities); Reagents & Kits, which form the essential chemical architecture of modern testing protocols.
  • Applications: Antibody screening for transfusion readiness and patient risk management; Blood transfusion protocols including compatibility testing; Disease diagnosis supporting hematologic investigations and patient management; Pregnancy-related antibody monitoring for safe maternal and neonatal outcomes.
  • End Users: Blood banks focusing on compliance and high-throughput processes; Diagnostic laboratories seeking workflow customization; Hospitals integrating immunohematology in acute care decision-making; Research institutes advancing reagent and system innovation.
  • Geographic Regions: Americas (including United States, Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (encompassing major and emerging healthcare markets); Asia-Pacific (with a focus on large-scale screening, public health investment, and accelerated reagent manufacturing).
  • Technologies: Automation (fully and semi-automated platforms), digital imaging, AI-driven agglutination pattern recognition, LIMS integration, and molecular immunohematology techniques for rare antigen profiling.
  • Company Coverage: Abbott Laboratories, AliveDx Suisse SA, Beckman Coulter, Inc., Bio-Rad Laboratories, Biomed Global, Cardinal Health, DIAGAST, Grifols, Avantor, QuidelOrtho Corporation.

Key Takeaways for Senior Leaders

  • The shift toward fully-automated analyzers and informatics-driven platforms is streamlining immunohematology workflows while supporting faster, more reliable diagnostic decisions.
  • Combining advanced reagent chemistry and AI-enabled digital technology enables labs to lower error margins and adapt quickly to novel assays or sudden workflow surges.
  • Molecular developments in immunohematology unlock new insights for personalized transfusion, enabling safer outcomes for patients with rare or complex serologic profiles.
  • Effective market strategies must be tailored to local healthcare infrastructure. In regions with robust IT frameworks, automation uptake advances rapidly. Growth in emerging markets is driven by investments in foundational screening and regional reagent partnerships.
  • Strategic alliances, mergers, and platform interoperability are reinforcing competitive differentiation and enabling companies to meet diverse clinical and budgetary requirements.
  • Cross-sector collaborations accelerate the translation of breakthroughs from research to practice and ensure long-term resilience in supply, innovation, and regulatory adaptation.

Tariff Impact: Adjustments and Operational Shifts

Recent U.S. tariff adjustments have added complexity to procurement, supply chain strategies, and cost structures in immunohematology. Manufacturers are responding by optimizing sourcing, leveraging domestic production, and forming regional alliances to maintain access to diagnostic components. Distributors face extended lead times, while healthcare providers adopt leaner inventory and collaborative cost-containment frameworks. These shifts are persuading facilities to carefully balance automation upgrades against elevated operating expenses in the current trade environment.

Methodology & Data Sources

This report utilizes a rigorous research framework, integrating direct interviews with laboratory directors, product managers, and regulatory specialists. Primary qualitative insights are strengthened by systematic reviews of peer-reviewed journals, industry white papers, publicly available regulatory filings, and patent databases. Data triangulation ensures accuracy and consistency across trends and regional dynamics.

Why This Report Matters

  • Supports decision-makers with actionable analysis to navigate automation adoption, supplier diversity, and evolving policy landscapes in the immunohematology market.
  • Enables tailored strategies for market entry, expansion, or process optimization based on detailed segmentation and regional intelligence.
  • Facilitates competitive benchmarking and investment prioritization for product innovation, alliances, and technology upgrades.

Conclusion

This comprehensive evaluation offers senior stakeholders a clear, strategic understanding of the immunohematology market’s drivers, challenges, and innovation pathways. Use these insights to build resilient, scalable diagnostics and deliver improvements in blood safety and patient outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Implementation of next-generation sequencing for comprehensive blood group antigen profiling in clinical labs
5.2. Adoption of point-of-care immunohematology analyzers for rapid emergency transfusion decision making
5.3. Expansion of automated red blood cell phenotyping systems to enhance rare donor identification workflows
5.4. Rising use of multiplexed bead-based assays for simultaneous detection of multiple alloantibodies in routine screening
5.5. Development of pathogen reduction technologies integrated with immunohematology testing to improve blood safety
5.6. Collaboration between biotechnology companies and hospitals to commercialize CRISPR-based antigen matching platforms
5.7. Regulatory approvals driving commercialization of fully automated ABO and RhD blood grouping analyzers in emerging markets
5.8. Increasing demand for cloud-based immunohematology data management solutions to streamline transfusion services
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Immunohematology Market, by Product Type
8.1. Introduction
8.2. Analyzers & Systems
8.2.1. Fully-Automated
8.2.2. Semi-Automated
8.3. Reagents & Kits
9. Immunohematology Market, by Application
9.1. Introduction
9.2. Antibody Screening
9.3. Blood Transfusion
9.4. Disease Diagnosis
9.5. Pregnancy
10. Immunohematology Market, by End-User
10.1. Introduction
10.2. Blood Banks
10.3. Diagnostic Laboratories
10.4. Hospitals
10.5. Research Institutes
11. Americas Immunohematology Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Immunohematology Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Immunohematology Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Abbott Laboratories
14.3.2. AliveDx Suisse SA
14.3.3. Beckman Coulter, Inc.
14.3.4. Bio-Rad Laboratories, Inc.
14.3.5. Biomed Global
14.3.6. Cardinal Health, Inc.
14.3.7. DIAGAST
14.3.8. Grifols, S.A.
14.3.9. Avantor, Inc.
14.3.10. QuidelOrtho Corporation
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. IMMUNOHEMATOLOGY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 12. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 14. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. IMMUNOHEMATOLOGY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 20. IMMUNOHEMATOLOGY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 21. IMMUNOHEMATOLOGY MARKET: RESEARCHAI
FIGURE 22. IMMUNOHEMATOLOGY MARKET: RESEARCHSTATISTICS
FIGURE 23. IMMUNOHEMATOLOGY MARKET: RESEARCHCONTACTS
FIGURE 24. IMMUNOHEMATOLOGY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. IMMUNOHEMATOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY FULLY-AUTOMATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY FULLY-AUTOMATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY SEMI-AUTOMATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY SEMI-AUTOMATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY ANTIBODY SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY ANTIBODY SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY BLOOD TRANSFUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY BLOOD TRANSFUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY PREGNANCY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY PREGNANCY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY BLOOD BANKS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 42. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 43. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 44. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 45. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 46. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 47. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 48. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 51. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 52. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 53. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 54. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 55. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 56. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 57. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 58. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 59. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 60. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 61. CANADA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 62. CANADA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 63. CANADA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 64. CANADA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 65. CANADA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 66. CANADA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 67. CANADA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 68. CANADA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 69. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 70. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 71. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 72. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 73. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 74. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 75. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 76. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 77. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 78. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 79. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 80. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 81. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 82. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 83. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 84. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 85. ARGENTINA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 86. ARGENTINA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 87. ARGENTINA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 88. ARGENTINA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 89. ARGENTINA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 90. ARGENTINA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 91. ARGENTINA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 92. ARGENTINA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 104. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 106. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 108. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 110. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 111. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 112. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 113. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 114. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 115. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 116. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 117. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 118. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 119. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 120. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 121. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 122. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 123. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 124. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 125. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 126. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 127. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 128. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 129. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 130. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 131. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 132. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 133. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 134. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 135. ITALY IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 136. ITALY IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 137. ITALY IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 138. ITALY IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 139. ITALY IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. ITALY IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. ITALY IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 142. ITALY IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 143. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 144. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 145. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 146. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 147. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 148. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 149. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 150. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 153. UNITED ARAB EMIRATES IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 154. UNITED ARAB EMIRATES IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 155. UNITED ARAB EMIRATES IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. UNITED ARAB EMIRATES IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. UNITED ARAB EMIRATES IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 158. UNITED ARAB EMIRATES IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 160. SAUDI ARABIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 162. SAUDI ARABIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. SAUDI ARABIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 166. SAUDI ARABIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 168. SOUTH AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 170. SOUTH AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 172. SOUTH AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 173. SOUTH AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 174. SOUTH AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 175. DENMARK IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. DENMARK IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. DENMARK IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 178. DENMARK IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 179. DENMARK IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. DENMARK IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. DENMARK IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 182. DENMARK IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 183. NETHERLANDS IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 184. NETHERLANDS IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 185. NETHERLANDS IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 186. NETHERLANDS IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 187. NETHERLANDS IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. NETHERLANDS IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. NETHERLANDS IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 190. NETHERLANDS IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 191. QATAR IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 192. QATAR IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 193. QATAR IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 194. QATAR IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 195. QATAR IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 196. QATAR IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 197. QATAR IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 198. QATAR IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 199. FINLAND IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. FINLAND IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. FINLAND IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 202. FINLAND IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 203. FINLAND IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. FINLAND IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. FINLAND IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 206. FINLAND IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 207. SWEDEN IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 208. SWEDEN IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 209. SWEDEN IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 210. SWEDEN IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 211. SWEDEN IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. SWEDEN IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. SWEDEN IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 214. SWEDEN IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 215. NIGERIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 216. NIGERIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 217. NIGERIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 218. NIGERIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 219. NIGERIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. NIGERIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. NIGERIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 222. NIGERIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 223. EGYPT IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 224. EGYPT IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 225. EGYPT IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 226. EGYPT IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 227. EGYPT IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 228. EGYPT IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 229. EGYPT IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 230. EGYPT IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 231. TURKEY IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. TURKEY IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. TURKEY IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 234. TURKEY IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 235. TURKEY IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. TURKEY IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. TURKEY IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 238. TURKEY IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 239. ISRAEL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 240. ISRAEL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 241. ISRAEL IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 242. ISRAEL IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 243. ISRAEL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. ISRAEL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. ISRAEL IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 246. ISRAEL IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 247. NORWAY IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 248. NORWAY IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 249. NORWAY IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 250. NORWAY IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 251. NORWAY IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. NORWAY IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. NORWAY IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 254. NORWAY IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 255. POLAND IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. POLAND IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. POLAND IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 258. POLAND IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 259. POLAND IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 260. POLAND IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 261. POLAND IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 262. POLAND IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 263. SWITZERLAND IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 264. SWITZERLAND IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 265. SWITZERLAND IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 266. SWITZERLAND IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 267. SWITZERLAND IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. SWITZERLAND IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. SWITZERLAND IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 270. SWITZERLAND IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 272. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 274. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 276. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 277. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 278. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 279. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 280. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 281. CHINA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 282. CHINA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 283. CHINA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 284. CHINA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 285. CHINA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. CHINA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. CHINA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 288. CHINA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 289. INDIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 290. INDIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 291. INDIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 292. INDIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 293. INDIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 294. INDIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 295. INDIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 296. INDIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 297. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 298. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 299. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 300. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 301. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 302. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 303. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 304. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 305. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 306. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 307. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 308. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 309. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 310. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 311. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 312. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 313. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 314. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 315. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 316. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 317. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 318. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 319. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 320. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 321. INDONESIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 322. INDONESIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 323. INDONESIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 324. INDONESIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 325. INDONESIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 326. INDONESIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 327. INDONESIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 328. INDONESIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 329. THAILAND IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 330. THAILAND IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 331. THAILAND IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 332. THAILAND IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 333. THAILAND IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 334. THAILAND IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 335. THAILAND IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 336. THAILAND IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 337. PHILIPPINES IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 338. PHILIPPINES IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 339. PHILIPPINES IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 340. PHILIPPINES IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 341. PHILIPPINES IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 342. PHILIPPINES IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 343. PHILIPPINES IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 344. PHILIPPINES IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 345. MALAYSIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 346. MALAYSIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 347. MALAYSIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 348. MALAYSIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2025-2030 (USD MILLION)
TABLE 349. MALAYSIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 350. MALAYSIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 351. MALAYSIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 352. MALAYSIA IMMUNOHEMATOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 353. SINGAPORE IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 354. SINGAPORE IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 355. SINGAPORE IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2024 (USD MILLION)
TABLE 356. SINGAPORE IMMUNOHEMATOLOGY

Samples

Loading
LOADING...

Companies Mentioned

  • Abbott Laboratories
  • AliveDx Suisse SA
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biomed Global
  • Cardinal Health, Inc.
  • DIAGAST
  • Grifols, S.A.
  • Avantor, Inc.
  • QuidelOrtho Corporation

Table Information

Report AttributeDetails
No. of Pages196
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.4 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.59 Billion
Compound Annual Growth Rate8.2%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Immunohematology Analyzers and Reagents - Global Strategic Business Report - Product Image

Immunohematology Analyzers and Reagents - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Immunohematology Market Report 2025 - Product Image

Immunohematology Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Immunohematology Market Opportunities and Strategies to 2034 - Product Image

Immunohematology Market Opportunities and Strategies to 2034

  • Report
  • 282 Pages
  • Global
From
Equine Hematology, Cytology, and Clinical Chemistry. Edition No. 2 - Product Image

Equine Hematology, Cytology, and Clinical Chemistry. Edition No. 2

  • Book
  • 352 Pages
Single-Use Chemiluminescent Immunoassay Analyzer Market by End User, Application, Product Type, Sample Type, Distribution Channel - Global Forecast 2025-2030 - Product Image

Single-Use Chemiluminescent Immunoassay Analyzer Market by End User, Application, Product Type, Sample Type, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From

About the Immunohematology Market

Immunohematology is a branch of medicine that focuses on the study of blood and its components, particularly the antigens and antibodies that are involved in the immune system. It is a key component of transfusion medicine, which is the practice of transfusing blood and its components to patients in need. Immunohematology is also used in the diagnosis and treatment of various blood disorders, such as hemophilia and sickle cell anemia. Immunohematology is a major part of the pharmaceutical industry, as it is used to develop and manufacture drugs and treatments for blood-related diseases. It is also used to develop and manufacture blood products, such as red blood cells, platelets, and plasma, for transfusion. Additionally, immunohematology is used to develop and manufacture diagnostic tests for blood-related diseases. Some companies in the immunohematology market include CSL Behring, Grifols, Octapharma, Kedrion, and Biotest. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.